Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Lansoprazole → Dexlansoprazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Lansoprazole | HCID 3883 | — |
| 반응물 | Hexane 2-propanol ethanol | HCID 22572948 | — |
| 용매 | Acetonitrile | HCID 6342 | — |
| 생성물 | Dexlansoprazole | HCID 9578005 | 40.2% |
반응 단계
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole (lansoprazole) (racemate) (3.98 g) was dissolved in the following mobile phase (330 ml) and acetonitrile (37 ml) and fractionated by HPLC (column: CHIRALCEL OD 20 mm dia.×250 mm, temperature: 30° C., mobile phase: hexane/2-propanol/ethanol=255/35/10, flowrate: 16 ml/min, detection wavelength: 285 nm, 1 shot: 20-25 mg). Fractions of optical isomers of shorter retention time were combined and concentrated; the individual lots were combined and dissolved in ethanol and filtered through a 0.45 μm filter; after hexane was added, the filtrate was again evaporated to dryness to yield R(+)-lansoprazole (1.6 g, optical purity >97.6% ee) as an amorphous substance.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07737282B2 |
| 출처 데이터셋 | uspto-grants-2010_06 |
| ORD ID | ord-52015cb62b724e32ad271bcd9e6e1bd5 |
| 출처 메모 | uspto-grants-2010_06 |